SRPT EPS Estimates
Sarepta Therapeutics, Inc.
$17.74
+$0.91(+5.38%)
50
Overall
60
Value
40
Tech
52
Quality
Market Cap
$1.78B
Volume
1.50M
52W Range
$14.68 - $24.68
Target Price
$21.35
SRPT EPS estimates: the consensus estimate for Sarepta Therapeutics, Inc.'s current fiscal year is $3.27 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SRPT EPS Estimates
- EPS estimate, current quarter
- $0.17
- EPS estimate, next quarter
- $-0.31
- EPS estimate, current year
- $3.27
- EPS estimate, next year
- $1.34
- EPS growth, 3-year
- +3.88%
| Fiscal year | EPS |
|---|---|
| 2025 | $-7.13 |
| 2024 | $2.47 |
| 2023 | $-5.80 |
| 2022 | $-8.03 |
| 2021 | $-5.15 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRPT | $17.74 | +5.4% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sarepta Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW